Doudna Jennifer A bought SCTX
July 27, 2026 · Form 4 insider transaction
Doudna Jennifer A bought 12,511 shares of Scribe Therapeutics Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,511
Price
N/A
Total value
N/A
InsiderDoudna Jennifer A
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeC: Conversion of a derivative
Transaction dateJuly 27, 2026
Filing dateJuly 29, 2026
Shares owned after603,547
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each share of Series A-1 Preferred Stock is convertible into Common Stock on a one-for 0.1689 basis at the option of the holder, and will convert automatically upon closing of the Issuer's initial public offering without payment of consideration. The Series A-1 Preferred Stock has no expiration date.